The aim of our current investigation was to evaluate whether NT-proBNP and BNP were associated with long-term cardiovascular or overall death independent of clinical cardiac remodelling measured as left ventricular hypertrophy (LVH), diastolic dysfunction and left ventricular ejection fraction (EF). This evidence concerns the gene NPPB and left ventricular hypertrophy.